These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25740072)

  • 1. Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity--An in silico Approach.
    Ramya LN; Pulicherla KK
    Pathol Oncol Res; 2015 Sep; 21(4):909-20. PubMed ID: 25740072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora.
    Belén LH; Lissabet JB; de Oliveira Rangel-Yagui C; Effer B; Monteiro G; Pessoa A; Farías Avendaño JG
    Biologicals; 2019 May; 59():47-55. PubMed ID: 30871932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering reduced-immunogenicity enzymes for amino acid depletion therapy in cancer.
    Cantor JR; Panayiotou V; Agnello G; Georgiou G; Stone EM
    Methods Enzymol; 2012; 502():291-319. PubMed ID: 22208990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
    Kotzia GA; Labrou NE
    J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
    Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
    Ln R; Doble M; Rekha VP; Pulicherla KK
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.
    Huerta-Saquero A; Evangelista-Martínez Z; Moreno-Enriquez A; Perez-Rueda E
    Bioengineered; 2013; 4(1):30-6. PubMed ID: 22895060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.
    Mehta RK; Verma S; Pati R; Sengupta M; Khatua B; Jena RK; Sethy S; Kar SK; Mandal C; Roehm KH; Sonawane A
    J Biol Chem; 2014 Feb; 289(6):3555-70. PubMed ID: 24297177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from
    Andrade KCR; Homem-de-Mello M; Motta JA; Borges MG; de Abreu JAC; de Souza PM; Pessoa A; Pappas GJ; de Oliveira Magalhães P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional insights into Erwinia carotovora L-asparaginase.
    Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
    FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
    Kumar S; Venkata Dasu V; Pakshirajan K
    Bioresour Technol; 2011 Jan; 102(2):2077-82. PubMed ID: 20832300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oligomerization of L-asparaginase from Erwinia carotovora].
    Mezentsev IuV; Mol'nar AA; Gnedenko OV; Krasotkina IuV; Sokolov NN; Ivanov AS
    Biomed Khim; 2006; 52(3):258-71. PubMed ID: 16898584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on pH and thermal stability of novel purified L-asparaginase from Pectobacterium carotojorum MTCC 1428.
    Kumar S; Dasu VV; Pakshirajan K
    Mikrobiologiia; 2011; 80(3):349-55. PubMed ID: 21861371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.
    Werner A; Röhm KH; Müller HJ
    Biol Chem; 2005 Jun; 386(6):535-40. PubMed ID: 16006240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing the immunogenicity of Erwinia chrysanthemi asparaginase via protein engineering: computational approach.
    Yari M; Eslami M; Ghoshoon MB; Nezafat N; Ghasemi Y
    Mol Biol Rep; 2019 Oct; 46(5):4751-4761. PubMed ID: 31290058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
    Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional role of Gly281 in L-asparaginase from Erwinia carotovora.
    Kotzia GA; Labrou NE
    Protein Pept Lett; 2013 Dec; 20(12):1302-7. PubMed ID: 24261975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumventing the side effects of L-asparaginase.
    Fonseca MHG; Fiúza TDS; Morais SB; Souza TACB; Trevizani R
    Biomed Pharmacother; 2021 Jul; 139():111616. PubMed ID: 33932739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.